Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-01-20
1988-07-19
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 1700, A61K 3147
Patent
active
047584270
ABSTRACT:
The absorption of orally administered substantially aqueous insoluble psychoactive 2-aryl-pyrazolo [4,3-C] quinolin-3-ones of the formula ##STR1## where R" is hydrogen, lower alkyl, lower alkoxy, hydroxy, halo or trifluoromethyl, and R' is hydrogen, lower alkyl, lower alkoxy, hydroxy, halo, trifluoromethyl, nitro, amino, mono- or di-lower alkylamino, mono- or di-lower alkylcarbamoylamino, mono- or di-lower alkylcarbamoyloxy or cyano, or a pharmaceutically acceptable salt thereof, is enhanced by administering the same in the form of a storage stable solid molecular dispersion of polyvinylpyrrolidone.
REFERENCES:
patent: 3895113 (1975-07-01), Omodei-Sale et al.
patent: 4038476 (1977-07-01), Atasoy et al.
patent: 4259331 (1981-03-01), Armstrong
patent: 4312870 (1982-01-01), Yokoyama
patent: 4374826 (1983-02-01), Armstrong
patent: 4524146 (1985-06-01), Yokoyama
Ciba-Geigy Corporation
Fishman Irving M.
Nutter Nathan M.
Phillips Delbert R.
LandOfFree
Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-596541